FRFHF on OTC
FAIRFAX FINANCIAL HOLDINGS LTD/ CAN
Fire company, listed on OTC (FRFHF). Summary from the record
Price unavailable
Last updated Oct 19, 2026.
Overview
Compare with American International Group, Arch Capital Group or Everest Re, or pick any stock.
Financials
From the company’s reports to the SEC. Every number links to the filing it came from.
Key numbers, fiscal 2022
Where the money goes
Where each dollar of revenue went, fiscal 2022
- Cost of revenue12¢$3.3B
- Other costs69¢$19.3B
- Interest2¢$452.8M
- Income tax4¢$1.1B
- Profit14¢$3.8B
Financial statements
No quarterly figures reported.
Every line of the income statement as filed: the last 2 fiscal years, latest first.2
| Period ending | 2025-12-31 | 2024-12-31 |
|---|---|---|
| Insurance revenue | $31.6B | $31.1B |
| Insurance service expenses | -$26.1B | -$24.9B |
| Net insurance result | $5.5B | $6.2B |
| Cost of reinsurance | -$5.5B | -$6.2B |
| Recoveries of insurance service expenses | $3.8B | $4.5B |
| Net reinsurance result | -$1.7B | -$1.7B |
| Insurance service result | $3.8B | $4.5B |
| Other insurance operating expenses | -$1.2B | -$1.2B |
| Net finance expense from insurance contracts | -$2.5B | -$1.8B |
| Net finance income from reinsurance contract assets held | $613.8M | $475.0M |
| Total | $860.5M | $2.0B |
| Interest and dividends | $2.6B | $2.5B |
| Share of profit of associates | $816.1M | $956.3M |
| Net gains on investments | $3.2B | $1.1B |
| Total | $6.5B | $4.5B |
| Non-insurance revenue | $8.5B | $6.7B |
| Non-insurance expenses | -$8.2B | -$6.5B |
| Interest expense | -$821.9M | -$649.0M |
| Corporate and other expenses | -$480.5M | -$450.2M |
| Total | -$961.7M | -$886.9M |
| Earnings before income taxes | $6.4B | $5.6B |
| Provision for income taxes | -$1.2B | -$1.4B |
| Net earnings | $5.3B | $4.3B |
| Shareholders of Fairfax | $4.8B | $3.9B |
| Non-controlling interests | $511.4M | $388.0M |
| Net earnings per share (in dollars per share) | $230.07 | $173.41 |
| Net earnings per diluted share (in dollars per share) | $213.78 | $160.56 |
| Cash dividends paid per share (in dollars per share) | $15.00 | $15.00 |
| Shares outstanding (000) (weighted average) (in shares) | 21.4M shares | 22.4M shares |
No quarter-by-quarter statement was filed.
No quarterly figures reported.
Every line of the balance sheet as filed: the last 3 fiscal years (annual) or 3 quarters (quarterly), latest first.2
| Period ending | 2025-12-31 | 2024-12-31 | 2023-12-31 |
|---|---|---|---|
| Holding company cash and investments (including assets pledged for derivative obligations - $207.8; December 31, 2024 - $193.6) | $2.7B | $2.5B | |
| Insurance contract receivables | $1.0B | $780.4M | |
| Subsidiary cash and short term investments (including restricted cash and cash equivalents - $640.4; December 31, 2024 - $1,240.7) | $9.0B | $7.6B | |
| Bonds (cost $39,655.2; December 31, 2024 - $37,852.9) | $40.0B | $37.4B | |
| Preferred stocks (cost $957.4; December 31, 2024 - $944.6) | $2.3B | $2.4B | |
| Common stocks (cost $7,926.0; December 31, 2024 - $7,116.1) | $9.2B | $7.5B | |
| Investments in associates (fair value $11,057.7; December 31, 2024 - $8,144.8) | $8.4B | $7.2B | |
| Derivatives and other invested assets (cost $1,312.7; December 31, 2024 - $903.9) | $1.8B | $1.2B | |
| Assets pledged for derivative obligations (cost $187.2; December 31, 2024 - $154.8) | $190.8M | $150.8M | |
| Fairfax India cash, portfolio investments and associates (fair value $3,685.1; December 31, 2024 - $3,163.3) | $2.1B | $1.9B | |
| Total portfolio investments | $72.9B | $65.2B | |
| Assets held for sale | $3.4B | ||
| Reinsurance contract assets held | $11.3B | $10.7B | |
| Deferred income tax assets | $367.1M | $325.0M | |
| Goodwill and intangible assets | $8.3B | $8.3B | $6.4B |
| Other assets | $7.7B | $9.0B | |
| Total assets | $107.8B | $96.8B | |
| Accounts payable and accrued liabilities | $6.1B | $6.1B | |
| Derivative obligations | $786.9M | $356.9M | |
| Liabilities associated with assets held for sale | $3.6B | ||
| Deferred income tax liabilities | $1.9B | $1.7B | |
| Insurance contract payables | $338.3M | $923.0M | |
| Insurance contract liabilities | $50.4B | $47.6B | |
| Borrowings | $13.6B | $11.8B | $9.7B |
| Total liabilities | $76.9B | $68.4B | |
| Shareholders' equity attributable to shareholders of Fairfax | $26.5B | $24.1B | |
| Non-controlling interests | $4.4B | $4.3B | |
| Total equity | $30.9B | $28.3B | $27.7B |
| Total liabilities and total equity | $107.8B | $96.8B | |
| Restricted cash and cash equivalents | $644.6M | $1.4B | |
| Investments in associates, at fair value | $11.1B | $8.1B |
| Period ending | 2025-12-31 | 2024-12-31 | 2023-12-31 |
|---|---|---|---|
| Holding company cash and investments (including assets pledged for derivative obligations - $207.8; December 31, 2024 - $193.6) | $2.7B | $2.5B | |
| Insurance contract receivables | $1.0B | $780.4M | |
| Subsidiary cash and short term investments (including restricted cash and cash equivalents - $640.4; December 31, 2024 - $1,240.7) | $9.0B | $7.6B | |
| Bonds (cost $39,655.2; December 31, 2024 - $37,852.9) | $40.0B | $37.4B | |
| Preferred stocks (cost $957.4; December 31, 2024 - $944.6) | $2.3B | $2.4B | |
| Common stocks (cost $7,926.0; December 31, 2024 - $7,116.1) | $9.2B | $7.5B | |
| Investments in associates (fair value $11,057.7; December 31, 2024 - $8,144.8) | $8.4B | $7.2B | |
| Derivatives and other invested assets (cost $1,312.7; December 31, 2024 - $903.9) | $1.8B | $1.2B | |
| Assets pledged for derivative obligations (cost $187.2; December 31, 2024 - $154.8) | $190.8M | $150.8M | |
| Fairfax India cash, portfolio investments and associates (fair value $3,685.1; December 31, 2024 - $3,163.3) | $2.1B | $1.9B | |
| Total portfolio investments | $72.9B | $65.2B | |
| Assets held for sale | $3.4B | ||
| Reinsurance contract assets held | $11.3B | $10.7B | |
| Deferred income tax assets | $367.1M | $325.0M | |
| Goodwill and intangible assets | $8.3B | $8.3B | $6.4B |
| Other assets | $7.7B | $9.0B | |
| Total assets | $107.8B | $96.8B | |
| Accounts payable and accrued liabilities | $6.1B | $6.1B | |
| Derivative obligations | $786.9M | $356.9M | |
| Liabilities associated with assets held for sale | $3.6B | ||
| Deferred income tax liabilities | $1.9B | $1.7B | |
| Insurance contract payables | $338.3M | $923.0M | |
| Insurance contract liabilities | $50.4B | $47.6B | |
| Borrowings | $13.6B | $11.8B | $9.7B |
| Total liabilities | $76.9B | $68.4B | |
| Shareholders' equity attributable to shareholders of Fairfax | $26.5B | $24.1B | |
| Non-controlling interests | $4.4B | $4.3B | |
| Total equity | $30.9B | $28.3B | $27.7B |
| Total liabilities and total equity | $107.8B | $96.8B | |
| Restricted cash and cash equivalents | $644.6M | $1.4B | |
| Investments in associates, at fair value | $11.1B | $8.1B |
Cash flow is reported year to date, not quarter by quarter, so there are no separate quarterly figures.
Every line of the cash flow as filed: the last 2 fiscal years, latest first.2
| Period ending | 2025-12-31 | 2024-12-31 |
|---|---|---|
| Net earnings | $5.3B | $4.3B |
| Depreciation, amortization and impairment charges | $783.8M | $753.8M |
| Net bond discount amortization | -$258.5M | -$310.2M |
| Amortization of share-based payment awards | $176.6M | $164.9M |
| Share of profit of associates | -$816.1M | -$956.3M |
| Deferred income taxes | $201.9M | $255.0M |
| Net gains on investments | -$3.2B | -$1.1B |
| Net purchases of investments classified at FVTPL | -$4.1B | -$515.8M |
| Changes in operating assets and liabilities | $4.3B | $1.4B |
| Cash provided by operating activities | $2.4B | $4.0B |
| Sales of investments in associates | $630.0M | $682.7M |
| Distributions and dividends from investments in associates | $740.0M | $419.6M |
| Purchases of investments in associates | -$1.3B | -$630.0M |
| Net purchases of premises and equipment and intangible assets | -$586.2M | -$408.8M |
| Net purchases of investment property | -$22.7M | -$33.0M |
| Purchases of subsidiaries, net of cash acquired | -$222.8M | -$1.4B |
| Deconsolidation of non-insurance subsidiaries | -$59.0M | |
| Cash used in investing activities | -$523.8M | -$1.3B |
| Purchases for treasury | -$189.1M | -$240.4M |
| Purchases for cancellation | -$1.6B | -$1.6B |
| Common share dividends | -$343.6M | -$363.1M |
| Redemptions | -$689.4M | -$173.8M |
| Dividends | -$24.5M | -$48.6M |
| Issuances to non-controlling interests, net of issuance costs | $14.9M | $1.3M |
| Purchases of non-controlling interests | -$181.3M | -$539.9M |
| Sales to non-controlling interests | $900.0K | |
| Dividends paid to non-controlling interests | -$181.8M | -$294.7M |
| Cash used in financing activities | -$1.8B | -$1.6B |
| Increase in cash and cash equivalents | $70.6M | $1.1B |
| Foreign currency translation | $59.7M | -$116.2M |
No quarter-by-quarter statement was filed.
Compare FAIRFAX FINANCIAL HOLDINGS LTD/ CAN with another company
Former names
Filings
257 filings to the SEC since October 2021: 5 annual reports, 27 large holders, 225 other. The latest 20:
- Oct 15, 20266-K EDGAR
- Oct 7, 20266-K EDGAR
- Sep 28, 20266-K EDGAR
- Sep 1, 20266-K EDGAR
- Aug 14, 202613F-HR EDGAR
- Jul 30, 20266-K EDGAR
- Jul 27, 20266-K EDGAR
- Jun 22, 20266-K EDGAR
- Jun 17, 20266-K EDGAR
- Jun 16, 20266-K EDGAR
- Jun 16, 2026SCHEDULE 13D/A EDGAR
- Jun 8, 20266-K EDGAR
- Jun 8, 20266-K EDGAR
- Jun 5, 20266-K EDGAR
- Jun 4, 20266-K EDGAR
- Jun 1, 20266-K EDGAR
- May 29, 20266-K EDGAR
- May 15, 202613F-HR EDGAR
- Apr 30, 20266-K EDGAR
- Apr 29, 20266-K EDGAR
The 257 filings since October 2021 can be filtered by form type and year here when JavaScript is on.
Every filing from the last five years, summarized. The full record is on SEC EDGAR.
Major holders
Investors who own more than 5% of the shares must tell the SEC: a 13D if they may seek to influence the company, a 13G if they hold passively.
- Prem Et Al Watsa V.SC 13G/A, 3 filings Feb 14, 2022 to Feb 14, 202410
Held by these funds
The largest holders among investment managers' 13F reports for the quarter ending Jun 30, 2026. Change is in shares since the quarter before.
| Fund | Shares | Value | Share of the fund | Change |
|---|---|---|---|---|
| Mraz, Amerine & Associates, Inc. | 29,425 | $48.5M | 7.0% | +323 |
| Elgethun Capital Management | 25,417 | $41.9M | 5.8% | +597 |
| Lawson Kroeker Investment Management Inc/ne | 6,575 | $10.8M | 3.0% | New |
| Check Capital Management Inc/ca | 5,937 | $9.8M | 0.2% | +5,718 |
| Kahn Brothers Group Inc | 1,018 | $1.7M | 0.3% | No change |
| Huntington National Bank | 1,000 | $1.6M | 0.0% | No change |
| Atlas Capital Advisors Inc. | 311 | $512.2K | 0.1% | −37 |
| Lountzis Asset Management, LLC | 244 | $401.8K | 0.1% | No change |
| Compass Financial Management LLC | 200 | $342.5K | 0.0% | New |
| Williams Jones Wealth Management, LLC. | 200 | $329.4K | 0.0% | No change |
| GAMMA Investing LLC | 108 | $177.9K | 0.0% | +10 |
| Ancora Advisors LLC | 28 | $46.0K | 0.0% | New |
| Salomon & Ludwin, LLC | 12 | $20.0K | 0.0% | No change |
| McMillan Office, Inc. | 12 | $19.8K | 0.0% | No change |
| Mn Services Vermogensbeheer B.V. | 5,553 | $9.1K | 0.1% | −2,100 |
| Hantz Financial Services, Inc. | 1 | $2 | 0.0% | No change |
13F reports cover disclosed long positions in U.S. stocks only.
Members of Congress who traded it
2 trades disclosed by members of Congress. “Vs S&P since” is the stock’s change since the trade minus the S&P 500’s.
| Date | Member | Trade | Amount | Vs S&P since | Filing |
|---|---|---|---|---|---|
| Jan 28, 2020 | Cindy Axne, House | Sale | $1,001 - $15,000 | −143.1% | Report |
| Jan 28, 2020 | Cindy Axne, House | Sale | $1,001 - $15,000 | −143.1% | Report |
Members report amounts as ranges, not exact figures. Returns are price-only (no dividends).
Sources
The numbers on this page point here. Each one links to the record it came from.
- 1
- 2
- 3
- 4
- 5
- 6
- 7
- 8
- 9
- 10